L 670596
Alternative Names: L 654664; L 657925; L 657926Latest Information Update: 25 Oct 2018
At a glance
- Originator Merck Frosst
- Class Antiallergics; Antiasthmatics; Antithrombotics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Ischaemic heart disorders